Clinical Trial Update: EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Pagoclone for persistent developmental stuttering has completed; the update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Developmental Stuttering

Drugs mentioned

• Pagoclone (pagoclone)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Persistent Developmental Stuttering | Phase 2 | Status: COMPLETED